Pacira Biosciences Inc
XBER:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
XBER:82P
|
US |
|
Saudi Telecom Company SJSC
SAU:7010
|
SA |
|
Isuzu Motors Ltd
F:ISUA
|
JP |
|
P
|
Postal Savings Bank of China Co Ltd
F:3YB
|
CN |
|
A
|
Aperam SA
XMUN:7AA
|
LU |
|
C
|
Covestro AG
SWB:1COV
|
DE |
|
Inpixon
NASDAQ:XTIA
|
US |
|
C
|
Cintas Corp
XBER:CIT
|
US |
|
Basf Se
OTC:BFFAF
|
DE |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 34.96 EUR with a low forecast of 26.84 EUR and a high forecast of 46.09 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
34.96
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 34.96 EUR with a low forecast of 26.84 EUR and a high forecast of 46.09 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 6%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
50%
The compound annual growth rate for Operating Income over the next 5 years is 50%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 7 years is 64%.
